nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2B6—Sorafenib—liver cancer	0.0898	0.446	CbGbCtD
Memantine—CYP2C19—Sorafenib—liver cancer	0.0571	0.283	CbGbCtD
Memantine—CYP2B6—Doxorubicin—liver cancer	0.0545	0.271	CbGbCtD
Memantine—Nasopharyngitis—Epirubicin—liver cancer	0.000586	0.00106	CcSEcCtD
Memantine—Gastritis—Epirubicin—liver cancer	0.00058	0.00105	CcSEcCtD
Memantine—Muscular weakness—Epirubicin—liver cancer	0.000578	0.00105	CcSEcCtD
Memantine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000578	0.00105	CcSEcCtD
Memantine—Cardiac arrest—Doxorubicin—liver cancer	0.000577	0.00105	CcSEcCtD
Memantine—Dizziness—Sorafenib—liver cancer	0.000577	0.00105	CcSEcCtD
Memantine—Mood swings—Doxorubicin—liver cancer	0.000575	0.00104	CcSEcCtD
Memantine—Ataxia—Doxorubicin—liver cancer	0.000571	0.00103	CcSEcCtD
Memantine—Blood creatinine increased—Doxorubicin—liver cancer	0.000568	0.00103	CcSEcCtD
Memantine—Dysphagia—Epirubicin—liver cancer	0.000567	0.00103	CcSEcCtD
Memantine—Influenza—Epirubicin—liver cancer	0.000567	0.00103	CcSEcCtD
Memantine—Asthma—Epirubicin—liver cancer	0.000567	0.00103	CcSEcCtD
Memantine—Dehydration—Doxorubicin—liver cancer	0.000564	0.00102	CcSEcCtD
Memantine—Liver function test abnormal—Doxorubicin—liver cancer	0.00056	0.00102	CcSEcCtD
Memantine—Dry skin—Doxorubicin—liver cancer	0.000556	0.00101	CcSEcCtD
Memantine—Pancreatitis—Epirubicin—liver cancer	0.000556	0.00101	CcSEcCtD
Memantine—Vomiting—Sorafenib—liver cancer	0.000555	0.00101	CcSEcCtD
Memantine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000554	0.001	CcSEcCtD
Memantine—Hypokalaemia—Doxorubicin—liver cancer	0.000552	0.001	CcSEcCtD
Memantine—Angina pectoris—Epirubicin—liver cancer	0.000552	0.001	CcSEcCtD
Memantine—Rash—Sorafenib—liver cancer	0.00055	0.000997	CcSEcCtD
Memantine—Dermatitis—Sorafenib—liver cancer	0.000549	0.000996	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000546	0.00099	CcSEcCtD
Memantine—Headache—Sorafenib—liver cancer	0.000546	0.00099	CcSEcCtD
Memantine—Bronchitis—Epirubicin—liver cancer	0.000545	0.000988	CcSEcCtD
Memantine—Nasopharyngitis—Doxorubicin—liver cancer	0.000543	0.000983	CcSEcCtD
Memantine—Pancytopenia—Epirubicin—liver cancer	0.000538	0.000976	CcSEcCtD
Memantine—Gastritis—Doxorubicin—liver cancer	0.000537	0.000973	CcSEcCtD
Memantine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000535	0.00097	CcSEcCtD
Memantine—Muscular weakness—Doxorubicin—liver cancer	0.000535	0.00097	CcSEcCtD
Memantine—Dysuria—Epirubicin—liver cancer	0.00053	0.000961	CcSEcCtD
Memantine—Neutropenia—Epirubicin—liver cancer	0.00053	0.000961	CcSEcCtD
Memantine—Upper respiratory tract infection—Epirubicin—liver cancer	0.000527	0.000955	CcSEcCtD
Memantine—Influenza—Doxorubicin—liver cancer	0.000524	0.000951	CcSEcCtD
Memantine—Asthma—Doxorubicin—liver cancer	0.000524	0.000951	CcSEcCtD
Memantine—Dysphagia—Doxorubicin—liver cancer	0.000524	0.000951	CcSEcCtD
Memantine—Pollakiuria—Epirubicin—liver cancer	0.000524	0.000949	CcSEcCtD
Memantine—Nausea—Sorafenib—liver cancer	0.000518	0.000939	CcSEcCtD
Memantine—Weight increased—Epirubicin—liver cancer	0.000516	0.000935	CcSEcCtD
Memantine—Pancreatitis—Doxorubicin—liver cancer	0.000514	0.000932	CcSEcCtD
Memantine—Weight decreased—Epirubicin—liver cancer	0.000513	0.000929	CcSEcCtD
Memantine—Hyperglycaemia—Epirubicin—liver cancer	0.000511	0.000927	CcSEcCtD
Memantine—Angina pectoris—Doxorubicin—liver cancer	0.000511	0.000926	CcSEcCtD
Memantine—Pneumonia—Epirubicin—liver cancer	0.000508	0.000921	CcSEcCtD
Memantine—Infestation NOS—Epirubicin—liver cancer	0.000505	0.000916	CcSEcCtD
Memantine—Infestation—Epirubicin—liver cancer	0.000505	0.000916	CcSEcCtD
Memantine—Bronchitis—Doxorubicin—liver cancer	0.000504	0.000914	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000501	0.000908	CcSEcCtD
Memantine—Pancytopenia—Doxorubicin—liver cancer	0.000498	0.000903	CcSEcCtD
Memantine—Renal failure—Epirubicin—liver cancer	0.000497	0.0009	CcSEcCtD
Memantine—Neuropathy peripheral—Epirubicin—liver cancer	0.000495	0.000898	CcSEcCtD
Memantine—Conjunctivitis—Epirubicin—liver cancer	0.000491	0.00089	CcSEcCtD
Memantine—Urinary tract infection—Epirubicin—liver cancer	0.000491	0.00089	CcSEcCtD
Memantine—Dysuria—Doxorubicin—liver cancer	0.00049	0.000889	CcSEcCtD
Memantine—Neutropenia—Doxorubicin—liver cancer	0.00049	0.000889	CcSEcCtD
Memantine—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000487	0.000883	CcSEcCtD
Memantine—Pollakiuria—Doxorubicin—liver cancer	0.000485	0.000878	CcSEcCtD
Memantine—Haematuria—Epirubicin—liver cancer	0.000482	0.000873	CcSEcCtD
Memantine—Hepatobiliary disease—Epirubicin—liver cancer	0.000478	0.000866	CcSEcCtD
Memantine—Weight increased—Doxorubicin—liver cancer	0.000477	0.000865	CcSEcCtD
Memantine—Epistaxis—Epirubicin—liver cancer	0.000477	0.000864	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—liver cancer	0.000475	0.00086	CcSEcCtD
Memantine—Sinusitis—Epirubicin—liver cancer	0.000474	0.000859	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—liver cancer	0.000473	0.000857	CcSEcCtD
Memantine—Agranulocytosis—Epirubicin—liver cancer	0.000472	0.000855	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—liver cancer	0.00047	0.000852	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—liver cancer	0.000468	0.000847	CcSEcCtD
Memantine—Infestation—Doxorubicin—liver cancer	0.000468	0.000847	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000464	0.00084	CcSEcCtD
Memantine—Bradycardia—Epirubicin—liver cancer	0.000462	0.000837	CcSEcCtD
Memantine—Renal failure—Doxorubicin—liver cancer	0.00046	0.000833	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000458	0.000831	CcSEcCtD
Memantine—Haemoglobin—Epirubicin—liver cancer	0.000456	0.000826	CcSEcCtD
Memantine—Rhinitis—Epirubicin—liver cancer	0.000455	0.000824	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—liver cancer	0.000455	0.000824	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—liver cancer	0.000455	0.000824	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—liver cancer	0.000454	0.000822	CcSEcCtD
Memantine—Hepatitis—Epirubicin—liver cancer	0.000454	0.000822	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—liver cancer	0.000451	0.000818	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—liver cancer	0.00045	0.000816	CcSEcCtD
Memantine—Urinary tract disorder—Epirubicin—liver cancer	0.000448	0.000812	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—liver cancer	0.000447	0.00081	CcSEcCtD
Memantine—Haematuria—Doxorubicin—liver cancer	0.000446	0.000808	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—liver cancer	0.000446	0.000808	CcSEcCtD
Memantine—Urethral disorder—Epirubicin—liver cancer	0.000445	0.000806	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—liver cancer	0.000442	0.000802	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—liver cancer	0.000441	0.000799	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—liver cancer	0.000439	0.000795	CcSEcCtD
Memantine—Visual impairment—Epirubicin—liver cancer	0.000437	0.000792	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—liver cancer	0.000436	0.000791	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—liver cancer	0.000429	0.000777	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—liver cancer	0.000427	0.000775	CcSEcCtD
Memantine—Eye disorder—Epirubicin—liver cancer	0.000424	0.000768	CcSEcCtD
Memantine—Tinnitus—Epirubicin—liver cancer	0.000423	0.000767	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—liver cancer	0.000422	0.000765	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—liver cancer	0.000421	0.000763	CcSEcCtD
Memantine—Flushing—Epirubicin—liver cancer	0.000421	0.000763	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—liver cancer	0.000421	0.000763	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—liver cancer	0.00042	0.000761	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—liver cancer	0.00042	0.000761	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—liver cancer	0.000418	0.000757	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—liver cancer	0.000417	0.000755	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—liver cancer	0.000415	0.000751	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—liver cancer	0.000414	0.000749	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—liver cancer	0.000413	0.000748	CcSEcCtD
Memantine—Angiopathy—Epirubicin—liver cancer	0.000412	0.000746	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—liver cancer	0.000412	0.000746	CcSEcCtD
Memantine—Immune system disorder—Epirubicin—liver cancer	0.00041	0.000743	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—liver cancer	0.000409	0.000741	CcSEcCtD
Memantine—Chills—Epirubicin—liver cancer	0.000407	0.000738	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—liver cancer	0.000405	0.000735	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—liver cancer	0.000405	0.000733	CcSEcCtD
Memantine—Alopecia—Epirubicin—liver cancer	0.000401	0.000727	CcSEcCtD
Memantine—Mental disorder—Epirubicin—liver cancer	0.000397	0.00072	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—liver cancer	0.000397	0.000719	CcSEcCtD
Memantine—Malnutrition—Epirubicin—liver cancer	0.000395	0.000716	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—liver cancer	0.000392	0.000711	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—liver cancer	0.000391	0.000709	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—liver cancer	0.00039	0.000706	CcSEcCtD
Memantine—Flushing—Doxorubicin—liver cancer	0.00039	0.000706	CcSEcCtD
Memantine—Flatulence—Epirubicin—liver cancer	0.000389	0.000705	CcSEcCtD
Memantine—Tension—Epirubicin—liver cancer	0.000388	0.000702	CcSEcCtD
Memantine—Dysgeusia—Epirubicin—liver cancer	0.000387	0.000701	CcSEcCtD
Memantine—Nervousness—Epirubicin—liver cancer	0.000384	0.000695	CcSEcCtD
Memantine—Back pain—Epirubicin—liver cancer	0.000382	0.000692	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—liver cancer	0.000381	0.00069	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—liver cancer	0.000379	0.000687	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—liver cancer	0.000378	0.000686	CcSEcCtD
Memantine—Chills—Doxorubicin—liver cancer	0.000377	0.000683	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—liver cancer	0.000375	0.00068	CcSEcCtD
Memantine—Vision blurred—Epirubicin—liver cancer	0.000372	0.000675	CcSEcCtD
Memantine—Alopecia—Doxorubicin—liver cancer	0.000371	0.000672	CcSEcCtD
Memantine—Mental disorder—Doxorubicin—liver cancer	0.000368	0.000667	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—liver cancer	0.000366	0.000664	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—liver cancer	0.000365	0.000662	CcSEcCtD
Memantine—Anaemia—Epirubicin—liver cancer	0.000365	0.000662	CcSEcCtD
Memantine—Agitation—Epirubicin—liver cancer	0.000363	0.000658	CcSEcCtD
Memantine—Flatulence—Doxorubicin—liver cancer	0.00036	0.000653	CcSEcCtD
Memantine—Tension—Doxorubicin—liver cancer	0.000359	0.00065	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—liver cancer	0.000358	0.000649	CcSEcCtD
Memantine—Malaise—Epirubicin—liver cancer	0.000356	0.000645	CcSEcCtD
Memantine—Nervousness—Doxorubicin—liver cancer	0.000355	0.000643	CcSEcCtD
Memantine—Vertigo—Epirubicin—liver cancer	0.000355	0.000643	CcSEcCtD
Memantine—Syncope—Epirubicin—liver cancer	0.000354	0.000642	CcSEcCtD
Memantine—Leukopenia—Epirubicin—liver cancer	0.000354	0.000641	CcSEcCtD
Memantine—Back pain—Doxorubicin—liver cancer	0.000353	0.000641	CcSEcCtD
Memantine—Palpitations—Epirubicin—liver cancer	0.000349	0.000633	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—liver cancer	0.000347	0.000629	CcSEcCtD
Memantine—Cough—Epirubicin—liver cancer	0.000345	0.000625	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—liver cancer	0.000344	0.000624	CcSEcCtD
Memantine—Convulsion—Epirubicin—liver cancer	0.000342	0.00062	CcSEcCtD
Memantine—Hypertension—Epirubicin—liver cancer	0.000341	0.000618	CcSEcCtD
Memantine—Ill-defined disorder—Doxorubicin—liver cancer	0.000339	0.000614	CcSEcCtD
Memantine—Anaemia—Doxorubicin—liver cancer	0.000338	0.000612	CcSEcCtD
Memantine—Chest pain—Epirubicin—liver cancer	0.000336	0.000609	CcSEcCtD
Memantine—Arthralgia—Epirubicin—liver cancer	0.000336	0.000609	CcSEcCtD
Memantine—Myalgia—Epirubicin—liver cancer	0.000336	0.000609	CcSEcCtD
Memantine—Agitation—Doxorubicin—liver cancer	0.000336	0.000609	CcSEcCtD
Memantine—Anxiety—Epirubicin—liver cancer	0.000335	0.000607	CcSEcCtD
Memantine—Discomfort—Epirubicin—liver cancer	0.000332	0.000602	CcSEcCtD
Memantine—Malaise—Doxorubicin—liver cancer	0.00033	0.000597	CcSEcCtD
Memantine—Dry mouth—Epirubicin—liver cancer	0.000329	0.000596	CcSEcCtD
Memantine—Vertigo—Doxorubicin—liver cancer	0.000328	0.000595	CcSEcCtD
Memantine—Syncope—Doxorubicin—liver cancer	0.000328	0.000594	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—liver cancer	0.000327	0.000593	CcSEcCtD
Memantine—Confusional state—Epirubicin—liver cancer	0.000325	0.000589	CcSEcCtD
Memantine—Palpitations—Doxorubicin—liver cancer	0.000323	0.000585	CcSEcCtD
Memantine—Oedema—Epirubicin—liver cancer	0.000322	0.000584	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—liver cancer	0.000321	0.000582	CcSEcCtD
Memantine—Infection—Epirubicin—liver cancer	0.00032	0.00058	CcSEcCtD
Memantine—Cough—Doxorubicin—liver cancer	0.000319	0.000578	CcSEcCtD
Memantine—Shock—Epirubicin—liver cancer	0.000317	0.000575	CcSEcCtD
Memantine—Convulsion—Doxorubicin—liver cancer	0.000317	0.000574	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—liver cancer	0.000316	0.000573	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—liver cancer	0.000316	0.000572	CcSEcCtD
Memantine—Hypertension—Doxorubicin—liver cancer	0.000316	0.000572	CcSEcCtD
Memantine—Tachycardia—Epirubicin—liver cancer	0.000315	0.00057	CcSEcCtD
Memantine—Skin disorder—Epirubicin—liver cancer	0.000313	0.000567	CcSEcCtD
Memantine—Hyperhidrosis—Epirubicin—liver cancer	0.000312	0.000565	CcSEcCtD
Memantine—Chest pain—Doxorubicin—liver cancer	0.000311	0.000564	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—liver cancer	0.000311	0.000564	CcSEcCtD
Memantine—Myalgia—Doxorubicin—liver cancer	0.000311	0.000564	CcSEcCtD
Memantine—Anxiety—Doxorubicin—liver cancer	0.00031	0.000562	CcSEcCtD
Memantine—Discomfort—Doxorubicin—liver cancer	0.000307	0.000557	CcSEcCtD
Memantine—Anorexia—Epirubicin—liver cancer	0.000307	0.000557	CcSEcCtD
Memantine—Dry mouth—Doxorubicin—liver cancer	0.000304	0.000551	CcSEcCtD
Memantine—Hypotension—Epirubicin—liver cancer	0.000301	0.000546	CcSEcCtD
Memantine—Confusional state—Doxorubicin—liver cancer	0.000301	0.000545	CcSEcCtD
Memantine—Oedema—Doxorubicin—liver cancer	0.000298	0.000541	CcSEcCtD
Memantine—Infection—Doxorubicin—liver cancer	0.000296	0.000537	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000294	0.000532	CcSEcCtD
Memantine—Shock—Doxorubicin—liver cancer	0.000293	0.000532	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—liver cancer	0.000292	0.00053	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—liver cancer	0.000292	0.000529	CcSEcCtD
Memantine—Insomnia—Epirubicin—liver cancer	0.000292	0.000528	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—liver cancer	0.000291	0.000528	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—liver cancer	0.00029	0.000525	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—liver cancer	0.000289	0.000525	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—liver cancer	0.000288	0.000523	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—liver cancer	0.000287	0.000521	CcSEcCtD
Memantine—Somnolence—Epirubicin—liver cancer	0.000287	0.000519	CcSEcCtD
Memantine—Anorexia—Doxorubicin—liver cancer	0.000284	0.000515	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—liver cancer	0.000284	0.000514	CcSEcCtD
Memantine—Decreased appetite—Epirubicin—liver cancer	0.00028	0.000508	CcSEcCtD
Memantine—Hypotension—Doxorubicin—liver cancer	0.000279	0.000505	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000278	0.000504	CcSEcCtD
Memantine—Fatigue—Epirubicin—liver cancer	0.000278	0.000504	CcSEcCtD
Memantine—Pain—Epirubicin—liver cancer	0.000276	0.0005	CcSEcCtD
Memantine—Constipation—Epirubicin—liver cancer	0.000276	0.0005	CcSEcCtD
Memantine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000272	0.000492	CcSEcCtD
Memantine—Insomnia—Doxorubicin—liver cancer	0.00027	0.000489	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—liver cancer	0.000268	0.000485	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—liver cancer	0.000266	0.000482	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—liver cancer	0.000266	0.000481	CcSEcCtD
Memantine—Somnolence—Doxorubicin—liver cancer	0.000265	0.000481	CcSEcCtD
Memantine—Gastrointestinal pain—Epirubicin—liver cancer	0.000264	0.000478	CcSEcCtD
Memantine—Dyspepsia—Doxorubicin—liver cancer	0.000263	0.000476	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—liver cancer	0.000259	0.00047	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000257	0.000467	CcSEcCtD
Memantine—Fatigue—Doxorubicin—liver cancer	0.000257	0.000466	CcSEcCtD
Memantine—Urticaria—Epirubicin—liver cancer	0.000256	0.000464	CcSEcCtD
Memantine—Pain—Doxorubicin—liver cancer	0.000255	0.000462	CcSEcCtD
Memantine—Constipation—Doxorubicin—liver cancer	0.000255	0.000462	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—liver cancer	0.000255	0.000462	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—liver cancer	0.000255	0.000462	CcSEcCtD
Memantine—Feeling abnormal—Doxorubicin—liver cancer	0.000246	0.000445	CcSEcCtD
Memantine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000244	0.000442	CcSEcCtD
Memantine—Hypersensitivity—Epirubicin—liver cancer	0.000237	0.00043	CcSEcCtD
Memantine—Urticaria—Doxorubicin—liver cancer	0.000237	0.000429	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—liver cancer	0.000236	0.000427	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—liver cancer	0.000236	0.000427	CcSEcCtD
Memantine—Asthenia—Epirubicin—liver cancer	0.000231	0.000419	CcSEcCtD
Memantine—Pruritus—Epirubicin—liver cancer	0.000228	0.000413	CcSEcCtD
Memantine—Diarrhoea—Epirubicin—liver cancer	0.000221	0.0004	CcSEcCtD
Memantine—Hypersensitivity—Doxorubicin—liver cancer	0.00022	0.000398	CcSEcCtD
Memantine—Asthenia—Doxorubicin—liver cancer	0.000214	0.000388	CcSEcCtD
Memantine—Dizziness—Epirubicin—liver cancer	0.000213	0.000386	CcSEcCtD
Memantine—Pruritus—Doxorubicin—liver cancer	0.000211	0.000382	CcSEcCtD
Memantine—Vomiting—Epirubicin—liver cancer	0.000205	0.000371	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—liver cancer	0.000204	0.00037	CcSEcCtD
Memantine—Rash—Epirubicin—liver cancer	0.000203	0.000368	CcSEcCtD
Memantine—Dermatitis—Epirubicin—liver cancer	0.000203	0.000368	CcSEcCtD
Memantine—Headache—Epirubicin—liver cancer	0.000202	0.000366	CcSEcCtD
Memantine—Dizziness—Doxorubicin—liver cancer	0.000197	0.000357	CcSEcCtD
Memantine—Nausea—Epirubicin—liver cancer	0.000191	0.000347	CcSEcCtD
Memantine—Vomiting—Doxorubicin—liver cancer	0.00019	0.000344	CcSEcCtD
Memantine—Rash—Doxorubicin—liver cancer	0.000188	0.000341	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—liver cancer	0.000188	0.00034	CcSEcCtD
Memantine—Headache—Doxorubicin—liver cancer	0.000187	0.000339	CcSEcCtD
Memantine—Nausea—Doxorubicin—liver cancer	0.000177	0.000321	CcSEcCtD
Memantine—SLC22A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000115	0.000468	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR4—liver cancer	0.000114	0.000461	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000112	0.000455	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—liver cancer	0.000109	0.000442	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TRIO—liver cancer	0.000108	0.000437	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CPT1B—liver cancer	0.000107	0.000434	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GLUL—liver cancer	0.000107	0.000434	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB1—liver cancer	0.000106	0.000431	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—liver cancer	0.000106	0.000431	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—liver cancer	0.000106	0.000428	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—liver cancer	0.000105	0.000423	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CTNNB1—liver cancer	0.000104	0.000421	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR4—liver cancer	0.000103	0.000419	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NR1H4—liver cancer	0.000103	0.000418	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—liver cancer	0.000102	0.000413	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—HRAS—liver cancer	0.000102	0.000413	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTA3—liver cancer	0.000102	0.000411	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CTNNB1—liver cancer	0.000101	0.000411	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—liver cancer	9.94e-05	0.000403	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	9.92e-05	0.000402	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—UGDH—liver cancer	9.9e-05	0.000401	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—JUN—liver cancer	9.88e-05	0.0004	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—RAF1—liver cancer	9.87e-05	0.0004	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CPT1B—liver cancer	9.83e-05	0.000398	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GLUL—liver cancer	9.83e-05	0.000398	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—HMOX1—liver cancer	9.77e-05	0.000396	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NR1H4—liver cancer	9.48e-05	0.000384	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—MAPK8—liver cancer	9.34e-05	0.000379	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTA3—liver cancer	9.32e-05	0.000378	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—EPT1—liver cancer	9.3e-05	0.000377	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTA4—liver cancer	9.29e-05	0.000376	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—HRAS—liver cancer	9.27e-05	0.000376	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—liver cancer	9.16e-05	0.000371	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—liver cancer	9.07e-05	0.000367	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTA2—liver cancer	9.05e-05	0.000367	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—liver cancer	9.04e-05	0.000366	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—liver cancer	8.93e-05	0.000362	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6—liver cancer	8.88e-05	0.00036	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—liver cancer	8.84e-05	0.000358	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TAT—liver cancer	8.82e-05	0.000357	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTA1—liver cancer	8.73e-05	0.000354	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	8.68e-05	0.000351	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6—liver cancer	8.65e-05	0.000351	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NAT2—liver cancer	8.63e-05	0.00035	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SHC3—liver cancer	8.6e-05	0.000348	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTA4—liver cancer	8.53e-05	0.000345	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TGFB1—liver cancer	8.41e-05	0.000341	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTA2—liver cancer	8.31e-05	0.000337	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALDOB—liver cancer	8.28e-05	0.000335	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TGFB1—liver cancer	8.19e-05	0.000332	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—F2—liver cancer	8.05e-05	0.000326	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTA1—liver cancer	8.02e-05	0.000325	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GLUL—liver cancer	7.93e-05	0.000321	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CPT1B—liver cancer	7.93e-05	0.000321	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NAT2—liver cancer	7.93e-05	0.000321	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CRABP1—liver cancer	7.9e-05	0.00032	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—PPARA—liver cancer	7.89e-05	0.00032	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—liver cancer	7.85e-05	0.000318	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—liver cancer	7.79e-05	0.000315	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—liver cancer	7.65e-05	0.00031	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NR1H4—liver cancer	7.65e-05	0.00031	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALDOB—liver cancer	7.6e-05	0.000308	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—liver cancer	7.59e-05	0.000307	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTA3—liver cancer	7.52e-05	0.000305	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CRABP1—liver cancer	7.25e-05	0.000294	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—liver cancer	7.09e-05	0.000287	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HPGDS—liver cancer	6.9e-05	0.00028	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTA4—liver cancer	6.88e-05	0.000279	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTA2—liver cancer	6.7e-05	0.000272	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FST—liver cancer	6.68e-05	0.000271	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—HRAS—liver cancer	6.62e-05	0.000268	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PRKCE—liver cancer	6.56e-05	0.000266	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—liver cancer	6.52e-05	0.000264	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.49e-05	0.000263	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTA1—liver cancer	6.47e-05	0.000262	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—liver cancer	6.45e-05	0.000261	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NAT2—liver cancer	6.4e-05	0.000259	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TRIO—liver cancer	6.37e-05	0.000258	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HPGDS—liver cancer	6.34e-05	0.000257	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—liver cancer	6.33e-05	0.000257	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—liver cancer	6.17e-05	0.00025	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PSMA4—liver cancer	6.15e-05	0.000249	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PSMD10—liver cancer	6.15e-05	0.000249	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALDOB—liver cancer	6.13e-05	0.000248	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR4—liver cancer	6.11e-05	0.000247	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CPT1B—liver cancer	6e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GLUL—liver cancer	6e-05	0.000243	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GOT2—liver cancer	5.98e-05	0.000242	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—liver cancer	5.97e-05	0.000242	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PRKCE—liver cancer	5.95e-05	0.000241	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—liver cancer	5.87e-05	0.000238	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CRABP1—liver cancer	5.85e-05	0.000237	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—liver cancer	5.84e-05	0.000237	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CSF2—liver cancer	5.8e-05	0.000235	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NR1H4—liver cancer	5.78e-05	0.000234	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—liver cancer	5.7e-05	0.000231	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA3—liver cancer	5.68e-05	0.00023	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PSMA4—liver cancer	5.65e-05	0.000229	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PSMD10—liver cancer	5.65e-05	0.000229	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2E1—liver cancer	5.63e-05	0.000228	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GOT2—liver cancer	5.49e-05	0.000223	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—liver cancer	5.43e-05	0.00022	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—RAF1—liver cancer	5.31e-05	0.000215	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CSF2—liver cancer	5.27e-05	0.000213	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYCS—liver cancer	5.26e-05	0.000213	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA4—liver cancer	5.2e-05	0.000211	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GOT1—liver cancer	5.17e-05	0.000209	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GGT1—liver cancer	5.17e-05	0.000209	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2E1—liver cancer	5.17e-05	0.000209	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HPGDS—liver cancer	5.11e-05	0.000207	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.08e-05	0.000206	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA2—liver cancer	5.07e-05	0.000205	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA1—liver cancer	4.89e-05	0.000198	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYCS—liver cancer	4.83e-05	0.000196	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NAT2—liver cancer	4.83e-05	0.000196	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADAM17—liver cancer	4.83e-05	0.000196	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GGT1—liver cancer	4.74e-05	0.000192	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GOT1—liver cancer	4.74e-05	0.000192	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.65e-05	0.000188	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTP1—liver cancer	4.64e-05	0.000188	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDOB—liver cancer	4.63e-05	0.000188	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—HMOX1—liver cancer	4.58e-05	0.000185	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSMA4—liver cancer	4.56e-05	0.000185	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PSMD10—liver cancer	4.56e-05	0.000185	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—F2—liver cancer	4.55e-05	0.000184	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSMD10—liver cancer	4.54e-05	0.000184	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PSMA4—liver cancer	4.54e-05	0.000184	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GOT2—liver cancer	4.43e-05	0.00018	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CRABP1—liver cancer	4.42e-05	0.000179	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—liver cancer	4.36e-05	0.000176	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—liver cancer	4.26e-05	0.000173	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTP1—liver cancer	4.26e-05	0.000173	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HMOX1—liver cancer	4.2e-05	0.00017	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2E1—liver cancer	4.17e-05	0.000169	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—F2—liver cancer	4.13e-05	0.000167	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1A1—liver cancer	4.04e-05	0.000164	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.98e-05	0.000161	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—liver cancer	3.96e-05	0.00016	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—liver cancer	3.91e-05	0.000159	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYCS—liver cancer	3.9e-05	0.000158	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HPGDS—liver cancer	3.86e-05	0.000157	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.84e-05	0.000156	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CD—liver cancer	3.83e-05	0.000155	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GGT1—liver cancer	3.83e-05	0.000155	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GOT1—liver cancer	3.83e-05	0.000155	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—MTHFR—liver cancer	3.77e-05	0.000153	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1A1—liver cancer	3.71e-05	0.00015	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARA—liver cancer	3.7e-05	0.00015	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRKCE—liver cancer	3.52e-05	0.000142	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.5e-05	0.000142	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CD—liver cancer	3.48e-05	0.000141	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—MTHFR—liver cancer	3.46e-05	0.00014	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.45e-05	0.00014	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSMD10—liver cancer	3.44e-05	0.000139	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PSMA4—liver cancer	3.44e-05	0.000139	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTP1—liver cancer	3.44e-05	0.000139	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARA—liver cancer	3.39e-05	0.000137	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HMOX1—liver cancer	3.39e-05	0.000137	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GOT2—liver cancer	3.35e-05	0.000136	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CB—liver cancer	3.34e-05	0.000135	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF2—liver cancer	3.33e-05	0.000135	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—liver cancer	3.17e-05	0.000128	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—liver cancer	3.16e-05	0.000128	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2E1—liver cancer	3.15e-05	0.000128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CSF2—liver cancer	3.11e-05	0.000126	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RAF1—liver cancer	3.1e-05	0.000126	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—H2AFX—liver cancer	3.07e-05	0.000124	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—liver cancer	3.07e-05	0.000124	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—liver cancer	3.06e-05	0.000124	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.05e-05	0.000124	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CB—liver cancer	3.03e-05	0.000123	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1A1—liver cancer	2.99e-05	0.000121	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYCS—liver cancer	2.95e-05	0.000119	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—liver cancer	2.91e-05	0.000118	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GOT1—liver cancer	2.89e-05	0.000117	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GGT1—liver cancer	2.89e-05	0.000117	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—liver cancer	2.81e-05	0.000114	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—MTHFR—liver cancer	2.79e-05	0.000113	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CD—liver cancer	2.78e-05	0.000113	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—liver cancer	2.78e-05	0.000113	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—liver cancer	2.77e-05	0.000112	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—liver cancer	2.75e-05	0.000111	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARA—liver cancer	2.74e-05	0.000111	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTP1—liver cancer	2.6e-05	0.000105	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HMOX1—liver cancer	2.56e-05	0.000104	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CD—liver cancer	2.56e-05	0.000104	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—liver cancer	2.54e-05	0.000103	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—liver cancer	2.52e-05	0.000102	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK14—liver cancer	2.52e-05	0.000102	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ESR1—liver cancer	2.47e-05	0.0001	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—F2—liver cancer	2.44e-05	9.89e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CB—liver cancer	2.43e-05	9.83e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—liver cancer	2.39e-05	9.67e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—liver cancer	2.35e-05	9.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—liver cancer	2.34e-05	9.47e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—liver cancer	2.34e-05	9.47e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—liver cancer	2.26e-05	9.17e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1A1—liver cancer	2.26e-05	9.17e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CB—liver cancer	2.23e-05	9.02e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—liver cancer	2.2e-05	8.9e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—MTHFR—liver cancer	2.11e-05	8.55e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARA—liver cancer	2.07e-05	8.38e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CD—liver cancer	2.06e-05	8.35e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CD—liver cancer	2.05e-05	8.32e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—liver cancer	2.04e-05	8.25e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—liver cancer	2.03e-05	8.24e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SERPINE1—liver cancer	2.03e-05	8.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—liver cancer	2.01e-05	8.15e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.86e-05	7.53e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—liver cancer	1.85e-05	7.48e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAF1—liver cancer	1.83e-05	7.43e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CB—liver cancer	1.8e-05	7.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MTOR—liver cancer	1.79e-05	7.25e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CB—liver cancer	1.79e-05	7.25e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—liver cancer	1.77e-05	7.18e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—liver cancer	1.71e-05	6.93e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—liver cancer	1.71e-05	6.92e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1B—liver cancer	1.68e-05	6.81e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—liver cancer	1.66e-05	6.73e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—liver cancer	1.65e-05	6.67e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—liver cancer	1.64e-05	6.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—liver cancer	1.64e-05	6.63e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—liver cancer	1.6e-05	6.49e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUN—liver cancer	1.6e-05	6.48e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CTNNB1—liver cancer	1.59e-05	6.43e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CD—liver cancer	1.56e-05	6.31e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—liver cancer	1.56e-05	6.3e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1A—liver cancer	1.55e-05	6.28e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—liver cancer	1.54e-05	6.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK8—liver cancer	1.51e-05	6.13e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—liver cancer	1.51e-05	6.11e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—liver cancer	1.48e-05	5.99e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—liver cancer	1.4e-05	5.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—liver cancer	1.38e-05	5.61e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CB—liver cancer	1.36e-05	5.5e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—liver cancer	1.36e-05	5.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—liver cancer	1.29e-05	5.21e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—liver cancer	1.28e-05	5.2e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—liver cancer	1.21e-05	4.89e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—liver cancer	1.19e-05	4.81e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—liver cancer	1.11e-05	4.49e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—liver cancer	1.1e-05	4.44e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—liver cancer	1.09e-05	4.42e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—liver cancer	1.06e-05	4.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—liver cancer	1.01e-05	4.09e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—liver cancer	9.67e-06	3.92e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—liver cancer	8.95e-06	3.63e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—liver cancer	8.92e-06	3.61e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—liver cancer	8.28e-06	3.35e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—liver cancer	6.76e-06	2.74e-05	CbGpPWpGaD
